Disneyland hikes cheapest tickets above $100 ahead of ‘Star Wars’ expansion
One-day ticket now $104 on low-demand days
All Posts in "Markets"
Government shutdown forces some cancellations at CES
FCC chief Ajit Pai, at least 9 other speakers cancel appearances at tech conference
Nikkei leaps amid broad gains for Asian markets
Japan stocks rise after Abe’s reassurance; tech stocks rebound in Asia
United Airlines: No more puppies on its planes
Another airline pulls back on its puppy policy. Emotional support animals are already restricted on several airlines
As housing costs remain high, parents buy homes to give their kids a leg up
In some housing markets, 25% of sales involve a co-buyer, such as a parent or other relative
Mueller investigation’s grand jury secures six-month extension from federal judge
The 18-month term would have expired this week
U.S. enjoys best manufacturing jobs growth of the last 30 years
Manufacturing employment in the U.S. is at the same level as 69 years ago
Bitcoin on track for 10th consecutive session below $4,000
Expect university endowments to be large players in the cryptocurrency market, says Nigel Green
Why one economist says investors are overreacting to recession whispers
Critical information for the U.S. trading day
Get to the airport early: Government shutdown could double security lines as TSA agents call out sick
Transportation Security Administration officials are currently working without pay
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Tweaking one setting on mechanical ventilators may help protect patients from lung injury
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
While FDA mulls Zevra’s rare disease med, Rafael merges with Cyclo to push their rival candidate
Despite mixed market, a venture capital revival could be coming in Europe: PitchBook
Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain
Ex-GSK CEO takes up board post at aging and obesity biotech BioAge
After $213M round, gene editing biotech Tome shrinks operations as investor sentiment worsens
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration